Gabather
3,21 SEK -5,87 %Vær den første som følger denne virksomhed
Gabather is a pharmaceutical company. Today, there is a business focus on developing drug candidates for the treatment of nerve diseases. Particular focus is on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are today patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
GABA
Daglig lav / høj pris
3,06 / 3,41
SEK
Markedsværdi
47,16 mio. SEK
Aktieomsætning
15,89 t SEK
Volumen
5,1 t
Finanskalender
Generalforsamling
30.06.2023
Delårsrapport
17.08.2023
Delårsrapport
09.11.2023
Viser Alle indholdstyper